345 related articles for article (PubMed ID: 33451103)
21. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
Gao S; Soares F; Wang S; Wong CC; Chen H; Yang Z; Liu W; Go MYY; Ahmed M; Zeng Y; O'Brien CA; Sung JJY; He HH; Yu J
Oncogene; 2021 Dec; 40(48):6601-6613. PubMed ID: 34621019
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
[TBL] [Abstract][Full Text] [Related]
23. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.
Toden S; Kunitoshi S; Cardenas J; Gu J; Hutchins E; Van Keuren-Jensen K; Uetake H; Toiyama Y; Goel A
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895943
[TBL] [Abstract][Full Text] [Related]
25. m
Zhang Y; Kang M; Zhang B; Meng F; Song J; Kaneko H; Shimamoto F; Tang B
Mol Cancer; 2019 Dec; 18(1):185. PubMed ID: 31849331
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
27. Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia.
Chang CW; Chen YS; Chen CC; Chan IO; Chen CC; Sheu SJ; Lin TW; Chou SH; Liu CJ; Lee TC; Lo JF
Oncotarget; 2016 Nov; 7(45):73016-73031. PubMed ID: 27682875
[TBL] [Abstract][Full Text] [Related]
28. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
[TBL] [Abstract][Full Text] [Related]
29. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells.
Guha D; Saha T; Bose S; Chakraborty S; Dhar S; Khan P; Adhikary A; Das T; Sa G
Apoptosis; 2019 Dec; 24(11-12):958-971. PubMed ID: 31641961
[TBL] [Abstract][Full Text] [Related]
30. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
31. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
Zhan Y; Qiu Y; Wang H; Wang Z; Xu J; Fan G; Xu J; Li W; Cao Y; Le VM; Ly HT; Yuan Z; Xu K; Yin P
Cancer Sci; 2020 May; 111(5):1619-1630. PubMed ID: 32058643
[TBL] [Abstract][Full Text] [Related]
32. [Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine].
Xu JH; Deng WL; Fan ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):743-7. PubMed ID: 20929136
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment.
Bedoui S; Dallel M; Barbirou M; Stayoussef M; Mokrani A; Mezlini A; Bouhaouala B; Almawi WY; Yacoubi-Loueslati B
Cancer Gene Ther; 2020 May; 27(5):311-318. PubMed ID: 31138901
[TBL] [Abstract][Full Text] [Related]
34. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
Ye J; Liu S; Shang Y; Chen H; Wang R
Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
[TBL] [Abstract][Full Text] [Related]
35. Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma.
Naik PP; Mukhopadhyay S; Panda PK; Sinha N; Das CK; Mishra R; Patil S; Bhutia SK
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29171106
[TBL] [Abstract][Full Text] [Related]
36. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
37. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation.
Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K
Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751
[TBL] [Abstract][Full Text] [Related]
38. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
40. Development of drug resistance in the population of colon cancer cells under the effect of multifunctional protein YB-1.
Vaiman AV; Stromskaya TP; Rybalkina EY; Sorokin AV; Ovchinnikov LP; Stavrovskaya AA
Bull Exp Biol Med; 2007 Apr; 143(4):463-6. PubMed ID: 18214301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
